10-K Filing

GRINDR INC. CIK: 1820144 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001140361-22-010575`
Period End Date	20211231
Filing Date	20220322
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	brhc10035213_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 43 Income Statement 16 Cash Flow Statement 49 Stockholders Equity 12

Balance Sheet 43 line items

Line Item	Tag	Value	Unit	Period
Preference shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preference shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preference shares, shares authorized (in shares)	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preference shares, shares authorized (in shares)	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preference shares, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$17.50K	USD	Point-in-time
Preference shares, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$1.14M	USD	Point-in-time
Preference shares, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preference shares, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$262.50K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$123.75K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.41M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$141.25K	USD	Point-in-time
Cash and Investments held in Trust Account	`AssetsHeldInTrustNoncurrent`	$278.77M	USD	Point-in-time
Cash and Investments held in Trust Account	`AssetsHeldInTrustNoncurrent`	$284.38M	USD	Point-in-time
Total Assets	`Assets`	$280.18M	USD	Point-in-time
Total Assets	`Assets`	$284.52M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$559.18K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.07K	USD	Point-in-time
Accrued offering costs	`AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent`	$26.78K	USD	Point-in-time
Accrued offering costs	`AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$559.18K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$63.85K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeePayableNonCurrent`	$9.66M	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeePayableNonCurrent`	$9.66M	USD	Point-in-time
Total Liabilities	`Liabilities`	$55.71M	USD	Point-in-time
Total Liabilities	`Liabilities`	$36.45M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A ordinary shares subject to possible redemption, $0.0001 par value; 27,600,000 shares at approximately $10.30 and $10.10 per share as of December 31, 2021 and 2020, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$284.28M	USD	Point-in-time
Class A ordinary shares subject to possible redemption, $0.0001 par value; 27,600,000 shares at approximately $10.30 and $10.10 per share as of December 31, 2021 and 2020, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$278.76M	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-36.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-54.29M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-36.21M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	-	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-54.29M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$284.52M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$280.18M	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
Operating costs	`OperatingExpenses`	$124.92K	USD	2 Qtrs
Operating costs	`OperatingExpenses`	$1.76M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-124.92K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.76M	USD	Annual
Interest earned on investments held in Trust Account	`InvestmentIncomeInterest`	$14.65K	USD	2 Qtrs
Interest earned on investments held in Trust Account	`InvestmentIncomeInterest`	$85.13K	USD	Annual
Fair value of private placement warrant in excess of purchase price	`FairValueOfPrivatePlacementWarrantInExcessOfPurchasePrice`	$-1.65M	USD	2 Qtrs
Fair value of private placement warrant in excess of purchase price	`FairValueOfPrivatePlacementWarrantInExcessOfPurchasePrice`	-	USD	Annual
Initial loss on forward purchase agreement liabilities	`InitialLossOnFairValueOfDerivativeLiabilityForwardPurchaseAgreement`	$3.40M	USD	2 Qtrs
Initial loss on forward purchase agreement liabilities	`InitialLossOnFairValueOfDerivativeLiabilityForwardPurchaseAgreement`	-	USD	Annual
Transaction costs allocable to derivatives	`TransactionCostsAllocableToDerivatives`	-	USD	Annual
Transaction costs allocable to derivatives	`TransactionCostsAllocableToDerivatives`	$928.45K	USD	2 Qtrs
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-20.73M	USD	2 Qtrs
Total other income (expenses), net	`NonoperatingIncomeExpense`	$24.96M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-20.85M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$23.19M	USD	Annual

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-20.85M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$23.19M	USD	Annual
Fair value of private placement warrant in excess of purchase price	`FairValueOfPrivatePlacementWarrantInExcessOfPurchasePrice`	$-1.65M	USD	2 Qtrs
Fair value of private placement warrant in excess of purchase price	`FairValueOfPrivatePlacementWarrantInExcessOfPurchasePrice`	-	USD	Annual
Interest earned on investments held in Trust Account	`InvestmentIncomeInterest`	$14.65K	USD	2 Qtrs
Interest earned on investments held in Trust Account	`InvestmentIncomeInterest`	$85.13K	USD	Annual
Initial loss on classification of forward purchase agreement liabilities	`FormationCostsPaidBySponsorInExchangeForIssuanceOfFounderShares`	-	USD	Annual
Initial loss on classification of forward purchase agreement liabilities	`FormationCostsPaidBySponsorInExchangeForIssuanceOfFounderShares`	$5.00K	USD	2 Qtrs
Initial loss on forward purchase agreement liabilities	`InitialLossOnFairValueOfDerivativeLiabilityForwardPurchaseAgreement`	$3.40M	USD	2 Qtrs
Initial loss on forward purchase agreement liabilities	`InitialLossOnFairValueOfDerivativeLiabilityForwardPurchaseAgreement`	-	USD	Annual
Transaction costs allocable to derivatives	`TransactionCostsAllocableToDerivatives`	-	USD	Annual
Transaction costs allocable to derivatives	`TransactionCostsAllocableToDerivatives`	$928.45K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-138.75K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$262.50K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$522.12K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$37.07K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-345.36K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.10M	USD	Annual
Investment of cash into Trust Account	`PaymentsToAcquireMarketableSecurities`	$278.76M	USD	Point-in-time
Investment of cash into Trust Account	`PaymentsToAcquireMarketableSecurities`	$278.76M	USD	2 Qtrs
Investment of cash into Trust Account	`PaymentsToAcquireMarketableSecurities`	$5.52M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.52M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-278.76M	USD	2 Qtrs
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromIssuanceInitialPublicOffering`	$270.48M	USD	2 Qtrs
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from promissory note - related party	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from promissory note - related party	`ProceedsFromRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Repayment of promissory note - related party	`RepaymentsOfRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Repayment of promissory note - related party	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$26.78K	USD	Annual
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$509.87K	USD	2 Qtrs
Proceeds from sale of Private Placements Warrants	`ProceedsFromIssuanceOfPrivatePlacement`	$10.28M	USD	2 Qtrs
Proceeds from sale of Private Placements Warrants	`ProceedsFromIssuanceOfPrivatePlacement`	$5.52M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.49M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$280.25M	USD	2 Qtrs
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.14M	USD	2 Qtrs
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.13M	USD	Annual
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.50K	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.14M	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.50K	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.14M	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Offering costs included in accrued offering costs	`OfferingCostsIncludedInAccruedOfferingCosts`	$26.78K	USD	2 Qtrs
Offering costs included in accrued offering costs	`OfferingCostsIncludedInAccruedOfferingCosts`	-	USD	Annual
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares	`OfferingCostsPaidFromProceedsFromIssuanceOfShares`	-	USD	Annual
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares	`OfferingCostsPaidFromProceedsFromIssuanceOfShares`	$20.00K	USD	2 Qtrs
Deferred underwriting fee payable	`DeferredUnderwritingFeeChargedToAdditionalPaidInCapital`	-	USD	Annual
Deferred underwriting fee payable	`DeferredUnderwritingFeeChargedToAdditionalPaidInCapital`	$9.66M	USD	2 Qtrs

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$-36.21M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	-	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-54.29M	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsors	`StockIssuedDuringPeriodValueIssuedForServices`	$25.00K	USD	2 Qtrs
Cash received in excess of fair value of Private Placement Warrants	`AdjustmentsToAdditionalPaidInCapitalCashPaidInExcessOfFairValueForPrivateWarrants`	$410.74K	USD	Annual
Accretion for Class A ordinary shares to redemption amount	`RedeemableOrdinarySharesAccretionToRedemptionValue`	$33.47M	USD	2 Qtrs
Accretion for Class A ordinary shares to redemption amount	`RedeemableOrdinarySharesAccretionToRedemptionValue`	$5.52M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-20.85M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$23.19M	USD	Annual
Ending balance	`StockholdersEquity`	$-36.21M	USD	Point-in-time
Ending balance	`StockholdersEquity`	-	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-54.29M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.